Recent RNAi Collaborations of Note Oct 17, 2003 Premium Save for later File Attachments RNALab101703.gif RNALab101703.gif Filed under Gene Silencing/Gene Editing RNAi Breaking News Illumina, Kartos Therapeutics Partner to Develop TP53 Companion Diagnostic Genomic Effects of Radiation From Chernobyl Nuclear Disaster Examined in New Studies Medicare Administrative Contractor Palmetto Finalizes Coverage of Molecular Testing for Organ Transplant Rejection 23andMe Team Sees Genetic, Nongenetic Contributors to COVID-19 Risk in Trans-Ancestry Study Todos Medical Acquires Provista Diagnostics for $7.5M Renalytix AI Lands US Government Contract for Kidney Disease Test The Scan Not Kept "Clean and Sanitary" A Food and Drug Administration inspection uncovered problems with cross contamination at an Emergent BioSolutions facility, the Wall Street Journal reports. Resumption Recommendation Expected The Washington Post reports that US officials are expected to give the go-ahead to resume using Johnson & Johnson's SARS-CoV-2 vaccine. Canada's New Budget on Science Science writes that Canada's new budget includes funding for the life sciences, but not as much as hoped for investigator-driven research. Nature Papers Examine Single-Cell, Multi-Omic SARS-CoV-2 Response; Flatfish Sequences; More In Nature this week: single-cell, multi-omics analysis provides insight into COVID-19 pathogenesis, evolution of flatfish, and more. What's Popular? Genome Editing Company EdiGene Raises RMB 400M in Series B Plus Financing Round